Assoc. Prof. HACER İLKE ÖNEN

Publication Network

Articles 53

1. Efficacy of Apoptic Agents in Cervical Cancer Treatment Servikal Kanser Tedavisinde Apopitotik Ajanlarin Etkinliği

Bostancı E. İ., ÖNEN H. İ.

Gazi Medical Journal , vol.36, no.2, pp.236-241, 2025 (ESCI)

2. The mechanistic role of curcumin and its analogs in NSCLC: An evaluation of cell death in preclinical studies

Kesen Boztaş E., Demiröz Ş. M., Önen H. İ.

Malignancy Spectrum , vol.1, no.4, pp.263-274, 2024 (Peer-Reviewed Journal)

3. The Relationship Between Serum miRNAs and Surgical Prognostic Factors in Gastric Cancers

Büyükkasap A. Ç., Küçükdiler E., Yılmaz N. S., Dağlı H., Önen H. İ., Aydoğdu Y. F., et al.

GAZI MEDICAL JOURNAL , vol.35, 2024 (ESCI)

4. Everolimus Pretreatment Protects the Lung From Ischemia-Reperfusion Injury

Demiröz Ş. M., Çelik A., Önen H. İ., Onen ,. I. H., Konaç E., Vargöl E., et al.

GAZI MEDICAL JOURNAL , vol.34, pp.160-166, 2023 (ESCI)

5. Everolimus Pretreatment Protects the Lung From Ischemia-Reperfusion Injury Everolimus Ön Tedavisi Akciǧer Iskemi-Reperfüzyon Hasarinda Koruyucudur

Demiröz Ş. M., Çelik A., Önen H. İ., Konaç E., Vargol E., Akyürek N., et al.

Gazi Medical Journal , vol.34, no.2, pp.160-166, 2023 (Scopus)

6. Resveratrol enhances the sensitivity of FL118 in triple-negative breast cancer cell lines via suppressing epithelial to mesenchymal transition

Yar Sağlam A. S., Kayhan H., Alp E., Önen H. İ.

MOLECULAR BIOLOGY REPORTS , vol.48, no.1, pp.475-489, 2021 (SCI-Expanded, Scopus) Sustainable Development

7. Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells

Deveci Ozkan A., Kaleli S., Önen H. İ., Sarıhan M., Guney Eskiler G., Kalaycı Yiğin A., et al.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY , vol.42, no.2, pp.93-100, 2020 (SCI-Expanded) Sustainable Development

8. PHENOXODIOL SENSITIZES METASTATIC COLORECTAL CANCER CELLS TO 5-FLUOROURACIL-AND OXALIPLATIN-INDUCED APOPTOSIS THROUGH INTRINSIC PATHWAY

Yaylaci E., Önen H. İ., Yar Sağlam A. S.

EXCLI JOURNAL , vol.19, pp.936-949, 2020 (SCI-Expanded, Scopus)

9. The Effects of Cisplatin on MTOR, AKT, CCND1 and STAT3 mRNA Expressions on HeLa Cells

Alp E., Yilmaz A., Önen H. İ., Konaç E., Ekmekci A., Menevse E. S., et al.

GAZI MEDICAL JOURNAL , vol.31, pp.5-9, 2020 (ESCI)

10. Emerging Potential Agents against Malignant Pleural Mesothelioma: A Review of in vitro Studies

Doru I. P., YAR SAĞLAM A. S., ÖNEN H. İ.

GAZI MEDICAL JOURNAL , vol.30, no.2, pp.231-236, 2019 (ESCI)

11. Transcriptomic expression levels of the VHL, TIMP-3, and RASSF1A genes in renal tumors

Ure I., Konac E., Alp E., Onen H. İ., Batur A. F., Gonul I. I., et al.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.23, no.21, pp.9313-9320, 2019 (SCI-Expanded)

12. Carboxylesterase1, alpha 2a adrenergic receptor and noradrenalin transporter gene polymorphisms and their clinical effects in attention deficit hyperactivity disorder in Turkish children

Çetin F. H., Isik Y., Torun Y., Alp E., Yilmaz A., Onen I. H.

Gene Reports , vol.11, pp.58-68, 2018 (Scopus)

13. EF24’ün dosetaksel ile sıralı uygulanmasının metastatik meme kanser hücre hattına etkisi

YAR SAĞLAM A. S., ELMAZOGLU Z., KAYHAN H., ÖNEN H. İ., YILMAZ A., MENEVŞE E. S.

Fırat Tıp Dergisi , 2018 (Peer-Reviewed Journal) Sustainable Development

14. Effects of EF-24, RAD001, and paclitaxel on the expression profiles of apoptotic and anti-apoptotic genes

Alp E., Yilmaz A., Önen H. İ., Menevse E. S.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , vol.13, no.2, pp.346-350, 2017 (SCI-Expanded) Sustainable Development

15. Upregulated mrna expression of mtor in surgically resected early stage non-small cell lung carcinoma: a potential molecular targeted therapy

SAYAN M., ÇELİK A., DEMİRÖZ Ş. M., ÖNEN H. İ., AKYÜREK N., KONAÇ E., et al.

Current Thoracic Surgery , vol.2, no.1, pp.5, 2017 (Peer-Reviewed Journal)

16. HDAC INHIBITORS, MS-275 AND SALERMIDE, POTENTIATES THE ANTICANCER EFFECT OF EF24 IN HUMAN PANCREATIC CANCER CELLS

YAR SAĞLAM A. S., Yilmaz A., ÖNEN H. İ., Alp E., KAYHAN H., Ekmekci A.

EXCLI JOURNAL , vol.15, pp.246-255, 2016 (SCI-Expanded, Scopus)

17. Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel

Yilmaz A., Alp E., ÖNEN H. İ., Menevse S.

WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY , vol.20, no.1, pp.28-32, 2016 (ESCI)

18. Flavopiridol Induces Apoptosis via Mitochondrial Pathway in B16F10 Murine Melanoma Cells and a Subcutaneous Melanoma Tumor Model

Gokce O., DOĞAN TURAÇLI İ., ÖNEN H. İ., ERDEM O. A., Kayaa E. E., Ekmekci A.

ACTA DERMATOVENEROLOGICA CROATICA , vol.24, no.1, pp.2-12, 2016 (SCI-Expanded, Scopus)

19. EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells

Onen H. İ., Yilmaz A., Alp E., Celik A., Demiroz Ş. M., Konac E., et al.

HUMAN & EXPERIMENTAL TOXICOLOGY , vol.34, no.2, pp.117-126, 2015 (SCI-Expanded, Scopus) Sustainable Development

20. The Impact of Gene Polymorphisms on the Success of Anticholinergic Treatment in Children with Overactive Bladder

Gurocak S., KONAÇ E., ÜRE İ., Senol C., Onen I. H., Sozen S., et al.

DISEASE MARKERS , vol.2015, pp.1-6, 2015 (SCI-Expanded)

21. Different surgical techniques and L-carnitine supplementation in an experimental varicocele model

Akdemir S., Gurocak S., Konac E., Ure I., Onen H. İ., Gonul I. I., et al.

ANDROLOGIA , vol.46, pp.910-916, 2014 (SCI-Expanded)

22. The Epigenetically Regulated Effects of Wnt Antagonists on the Expression of Genes in the Apoptosis Pathway in Human Bladder Cancer Cell Line (T24)

Varol N., Konaç E., Onen I. H., Gurocak S., Alp E., Yilmaz A., et al.

DNA AND CELL BIOLOGY , vol.33, no.7, pp.408-417, 2014 (SCI-Expanded) Sustainable Development

23. EFFECTS OF MELOXICAM, ALONE AND IN COMBINATION WITH CHEMOTHERAPEUTIC AGENTS ON THE RAF/MEK/ERK PATHWAY IN RAJI CELLS

ÖNEN H. İ., Yilmaz A., Alp E., YAR SAĞLAM A. S., KONAÇ E., Menevse S.

ACTA MEDICA MEDITERRANEA , vol.30, no.3, pp.717-723, 2014 (SCI-Expanded, Scopus)

24. Enhanced Cisplatin Response with Histone Acetyl Transferase Inhibitor, Anacardic Acid, in Malignant Pleural Mesothelioma Cell Line

ÖNEN H. İ., YILMAZ A., ALP E., ÇELİK A., DEMİRÖZ Ş. M., TAŞTEPE A. İ., et al.

Türkiye Klinikleri Tıp Bilimleri Dergisi , vol.33, no.2, pp.478-484, 2013 (Scopus)

25. Malign Plevral Mezotelyoma Hücre Hattında Histon Asetil Transferaz İnhibitörü olan Anakardik Asitin Sisplatin Cevabını Arttırıcı Etkisi

Önen H. İ., Yılmaz A., Alp E., Çelik A., Demiröz M. Ş., Taştepe A. İ., et al.

Turkiye Klinikleri J Med Sci , vol.33, no.2, pp.478-484, 2013 (Peer-Reviewed Journal)

26. Effects of cisplatin and panobinostat on human mesothelial (Met-5A) and malignant pleural mesothelioma (MSTO-211H) cells

Gultekin K. E., Yurdakonar M. K., Yaman E., Yuce U. S., Yilmaz A., Alp E., et al.

GENETICS AND MOLECULAR RESEARCH , vol.12, no.4, pp.5405-5413, 2013 (SCI-Expanded, Scopus) Sustainable Development

27. NLF2 gene expression in the endometrium of patients with implantation failure after IVF treatment

Turkyilmaz E., Guner H., ERDEM M., ERDEM A., Biri A. A., KONAÇ E., et al.

GENE , vol.508, no.1, pp.140-143, 2012 (SCI-Expanded) Sustainable Development

28. Evaluation of the Effects of the Flavonoid Apigenin on Apoptotic Pathway Gene Expression on the Colon Cancer Cell Line (HT29)

Turktekin M., Konaç E., Önen H. İ., Alp E., Yilmaz A., Menevse S.

JOURNAL OF MEDICINAL FOOD , vol.14, no.10, pp.1107-1117, 2011 (SCI-Expanded) Sustainable Development

29. Place of MicroRNA (miRNA) in urooncology and its importance

Konaç E., Önen H. İ., Sözen T. S.

Üroonkoloji Bülteni , vol.9, no.1, pp.3, 2010 (Peer-Reviewed Journal)

30. Expression of the imprinted IGF2 and H19 genes in the endometrium of cases with unexplained infertility

Korucuoglu U., Biri A. A., KONAÇ E., Alp E., Onen I. H., İLHAN M. N., et al.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY , vol.149, no.1, pp.77-81, 2010 (SCI-Expanded, Scopus) Sustainable Development

31. Effects of meloxicam, lornoxicam, alone and in combination with chemotherapeutic agents on the RAF/MEK/ERK pathway in Raji cells

ÖNEN H. İ., Yilmaz A., Alp E., YAR SAĞLAM A. S., KONAÇ E., Menevse S.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE , vol.26, 2010 (SCI-Expanded)

32. The pan deacetylase inhibitor panobinostat inhibits growth of human burkitt's lymphoma cell line (Raji)

ÖNEN H. İ., DOĞAN İ., Ergin V., KONAÇ E., Ekmekci A., Menevse A.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE , vol.26, 2010 (SCI-Expanded)

33. Evaluation of in vitro fertilization parameters and estrogen receptor alpha gene polymorphisms for women with unexplained infertility

Ayvaz O. U., Ekmekci A., Baltaci V., Önen H. İ., Unsal E.

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS , vol.26, pp.503-510, 2009 (SCI-Expanded)

34. Genetic Variations in the Hypoxia-Inducible Factor-1 alpha Gene and Lung Cancer

KONAÇ E., DOĞAN İ., ÖNEN H. İ., YURDAKUL A. S., ÖZTÜRK C., Varol A., et al.

EXPERIMENTAL BIOLOGY AND MEDICINE , vol.234, no.9, pp.1109-1116, 2009 (SCI-Expanded) Sustainable Development

35. Endometrial mRNA expression of matrix metalloproteinases, their tissue inhibitors and cell adhesion molecules in unexplained infertility and implantation failure patients

KONAÇ E., Alp E., ÖNEN H. İ., Korucuoglu U., Biri A. A., Menevse S.

REPRODUCTIVE BIOMEDICINE ONLINE , vol.19, no.3, pp.391-397, 2009 (SCI-Expanded) Sustainable Development

36. Polymorphisms in the vitamin D receptor gene and risk of lung cancer

Doğan İ., Önen H. İ., Yurdakul A. S., Konaç E., Öztürk C., Varol A., et al.

MEDICAL SCIENCE MONITOR , vol.15, 2009 (SCI-Expanded) Sustainable Development

37. Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome

CİNAZ P., Yesilkaya E., Tugba T. U., KONAÇ E., Yilmaz A., BİDECİ A., et al.

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS , vol.26, no.4, pp.205-216, 2009 (SCI-Expanded) Sustainable Development

38. Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome

Cinaz P., Yesilkaya E., Tabanlıgil Calam T., Konaç E., Yilmaz A., Bideci A., et al.

HORMONE RESEARCH , pp.395, 2009 (SCI-Expanded)

39. Association of Genetic Polymorphisms in Vitamin D Receptor Gene and Susceptibility to Sporadic Prostate Cancer

Onen I. H., Ekmekci A., Eroglu M., Konaç E., Yeşil S., Biri H.

EXPERIMENTAL BIOLOGY AND MEDICINE , vol.233, pp.1608-1614, 2008 (SCI-Expanded)

40. Gene Polymorphism and Cancer Susceptibility

Ekmekçi A., Konaç E., Önen H. İ.

Marmara Medical Journal , vol.21, no.3, pp.244-257, 2008 (Scopus)

41. Polymorphisms in the Aurora-A gene is not associated with lung cancer in the Turkish population

Doğan İ., Ekmekci A., Yurdakul A. S., Onen I. H., Öztürk C., Cirak M. Y., et al.

DNA AND CELL BIOLOGY , vol.27, no.8, pp.443-448, 2008 (SCI-Expanded) Sustainable Development

42. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 alpha (HIF-1 alpha) gene in human sporadic breast cancer

Apaydin I., Konaç E., Önen H. İ., Akbaba M., Tekin E., Ekmekci A.

ARCHIVES OF MEDICAL RESEARCH , vol.39, pp.338-345, 2008 (SCI-Expanded)

43. No association between polymorphism in the vascular endothelial growth factor gene at position-460 and sporadic prostate cancer in the Turkish population

Onen I. H., KONAÇ E., Eroglu M., Guneri C., Biri H., Ekmekci A.

MOLECULAR BIOLOGY REPORTS , vol.35, no.1, pp.17-22, 2008 (SCI-Expanded) Sustainable Development

44. GENE POLYMORPHISM AND GENETIC SUSCEPTIBILITY TO CANCER

Ekmekci A., KONAÇ E., ÖNEN H. İ.

MARMARA MEDICAL JOURNAL , no.3, pp.282-295, 2008 (ESCI) Sustainable Development

45. Apolipoprotein e gene polymorphism in nonalcoholic fatty liver disease

Demirag M. D., Onen H. İ., Karaoguz M., Dogan İ., Karakan T., Ekmekci A., et al.

DIGESTIVE DISEASES AND SCIENCES , vol.52, no.12, pp.3399-3403, 2007 (SCI-Expanded) Sustainable Development

46. Angiopoietin-2 gene polymorphism in sporadic prostate cancer

Önen H. İ., Konaç E., Eroǧlu M., Ekmekçi A.

Gazi Medical Journal , vol.18, pp.121-126, 2007 (ESCI)

47. Lack of association between -460 C/T and 936 C/T of the vascular endothelial growth factor and angiopoietin-2 exon 4 G/A polymorphisms and ovarian, cervical, and endometrial cancers

Konac E., Onen H. İ., Metindir J., Alp E., Biri A. A., Ekmekci A.

DNA AND CELL BIOLOGY , vol.26, pp.453-463, 2007 (SCI-Expanded) Sustainable Development

48. An investigation of relationships between hypoxia-inducible factor-1α gene polymorphisms and ovarian, cervical and endometrial cancers

Konac E., Onen H. İ., Metindir J., Alp E., Biri A. A., Ekmekci A.

Cancer Detection and Prevention , vol.31, pp.102-109, 2007 (SCI-Expanded) Sustainable Development

49. The association of 5 alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population

Onen I. H., Ekmekci A., Eroglu M., Polat F., Biri H.

DNA AND CELL BIOLOGY , vol.26, no.2, pp.100-107, 2007 (SCI-Expanded) Sustainable Development

50. Angiopoietin 2 gene polymorphism in the sporadic prostate cancer

ÖNEN H. İ., KONAÇ E., EROĞLU M., EKMEKÇİ A.

Gazi Medical Journal , vol.18, no.3, pp.121-126, 2007 (Scopus) Sustainable Development

51. The relationship between vascular endothelial growth factor -634G>C polymorphism and ovarian, cervical and endometrial cancers

Konaç E., Önen H. İ., Metindir J., Almayanlar E., Biri A. A., Ekmekçi A.

Korean Journal of Genetics , vol.28, pp.99-107, 2006 (SCI-Expanded)

52. The relationship between apolipoprotein E genotypes and alcoholism in type II alcoholics

Karaoguz M., Onen I., Cosar B.

KOREAN JOURNAL OF GENETICS , vol.27, no.1, pp.19-23, 2005 (SCI-Expanded) Sustainable Development

53. Lack of association between TaqIA RFLP of the dopamine D2 receptor gene and alcoholism in type II Turkish alcoholics

Karaoguz M., Onen I., Cosar B., Arikan Z., Sahin F., Menevse A.

KOREAN JOURNAL OF GENETICS , vol.26, no.2, pp.149-154, 2004 (SCI-Expanded) Sustainable Development

Papers Presented at Peer-Reviewed Scientific Conferences 36

1. Determination of the Effect of EF24 on Cisplatin-induced Cell Death Response in Triple Negative Breast Cancer Cells

SÖYLEMEZ S., Deletioğlu V., ÖNEN H. İ., CANBOLAT O.

9th International Congress of the Molecular Biology Association of Turkey, Turkey, 12 - 14 September 2024, pp.171, (Summary Text)

2. Kolorektal Kanser için Değiştirilebilir Bir Risk Faktörü Olarak Beslenme: Gözlemsel Vaka-Kontrol Çalışması

YASSIBAŞ E., ÖNEN H. İ., KEREM M., TOKA O., SAMUR F. G.

3. Uluslararası Akdeniz Bilimsel Araştırmalar ve İnovasyon Kongresi, Antalya, Turkey, 26 - 27 August 2023, (Full Text)

3. Gastrik Kanser Olgularında Serum Mirna Düzeyleri ve Prognostik Faktörler Arasındaki İlişkinin Gösterilmesi

BÜYÜKKASAP A. Ç., KÜÇÜKDİLER E., NASİROV M., YILMAZ N. S., DAĞLI H., ÖNEN H. İ., et al.

13th International Medicine and Health Sciences Researches Congress, 26 - 27 August 2023, (Full Text)

4. Resveratrol ile önkoşullamanın ardından FL118 uygulamasının üçlü negatif meme kanseri hücre dizilerinde epitelyal mezenkimal geçiş üzerindeki etkisi

YAR SAĞLAM A. S., KAYHAN H., ALP E., ÖNEN H. İ.

XVII. Tıbbi Biyoloji ve Genetik Kongresi, 28 October 2021, vol.52, pp.76-77, (Summary Text) Sustainable Development

5. The Relationship Between Serum Mirna Levels and Prognostic Factors Ii Gastric Cancer

Büyükkasap A. Ç., Küçükdiler E., Nasirov M., Yılmaz N. S., Dağlı H., Önen H. İ., et al.

2. INTERNATIONAL CANCER DAYS (2ND ICD), Sivas, Turkey, 16 September 2021, (Full Text) Sustainable Development

6. Phenoxodiol Sensitizes Metastatic Colorectal Cancer Cells to 5-Fluorouracil- and Oxaliplatin-Induced Apoptosis through Mitochondrial Intrinsic Pathway.

YAYLACI E., ÖNEN H. İ., YAR SAĞLAM A. S.

VII. International Congress of Molecular Medicine, 5 - 07 September 2019, (Summary Text) Sustainable Development

7. Investigation of the Effect of Flavonoid Nobiletin on TLR4 Signaling Pathway in Prostate Cancer Cell Lines

DEVECİ A., KALELİ S., ÖNEN H. İ., AKSOY Ö., Kaleli H. N., GÜLER E. M., et al.

The 43rd FEBS CONGRESS, PRAGUE, Czech Republic, 7 - 12 July 2018, vol.8, pp.329, (Summary Text) Sustainable Development

8. 5-Florourasil ve okzaliplatin ile indüklenmiş apoptozun fenoksodiol uygulaması ile metastatik kolorektal kanser hücrelerini mitokondiyal içsel yolak aracılığıyla duyarlı hale getirmesi.

YAYLACI E., ÖNEN H. İ., YAR SAĞLAM A. S.

7. Ulusal Moleküler Biyoloji ve Biyoteknoloji Kongresi, Turkey, 2 - 05 July 2018, (Summary Text) Sustainable Development

9. Amiloid beta peptid 1-42 ile oluşturulan deneysel alzheimer modelinde PSD-95 inhibitörünün nöronal koruma, öğrenme ve hafıza fonksiyonları üzerine etkisi

Yar Sağlam A. S., Elmazoğlu Z., Güney Ş., Önen H. İ., Seymen C. M., Take Kaplanoğlu G., et al.

XV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Antalya, Turkey, 26 - 29 October 2017, (Summary Text)

10. The effects of sequential administration of EF24 with docetaxel apoptotic response in metastatic breast cancer cell line

YAR SAĞLAM A. S., ELMAZOGLU Z., KAYHAN H., ÖNEN H. İ., YILMAZ A., MENEVŞE E. S.

VI. International Congress of Molecular Medicine, 22 - 25 May 2017, (Summary Text) Sustainable Development

11. Apoptotic effect of anacardic acid and farnesyl transferaz inhibitör on metastatic breast cancer cell line (MCF-7).

YILDIRIM E. F., YAR SAĞLAM A. S., ELMAZOGLU Z., KAYHAN H., ÖNEN H. İ.

VI. International Congress of Molecular Medicine, 22 - 25 May 2017, (Summary Text) Sustainable Development

12. HDAC inhibitors MS 275 and salermide potentiates the anticancer effect of EF24 in human pancreatic cancer cells

YAR SAĞLAM A. S., YILMAZ A., ÖNEN H. İ., ALP E., KAYHAN H., EKMEKÇİ A.

6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, (Summary Text) Sustainable Development

13. Laboratuvar tıbbi atıklarının imhası ve cihaz atıklarının nötralizasyonunda Türkiye deki son durum

YILMAZ-DEMİRTAŞ C., ÖZTÜRK FİNCAN G. S., ÖNEN H. İ., TANER M. E.

1st international Urban Environment Health Congress, 11 - 15 May 2016, (Summary Text)

14. Gazi Üniversitesi Sağlık Uygulama ve Araştırma Merkezi nin 2014 ve 2015 yıllarına ait tehlikeli atık miktarı ve bertaraf maliyeti

ÖZTÜRK FİNCAN G. S., ÖNEN H. İ., YILMAZ-DEMİRTAŞ C., TANER M. E.

1 st International Urban Environment Health Congress, 11 - 15 May 2016, (Summary Text) Sustainable Development

15. Gazi Üniversitesi Sağlık Uygulama ve Araştırma Merkezi nin 2015 yılı tıbbi atık miktarı ve bertaraf maliyet analizi

ÖNEN H. İ., YILMAZ-DEMİRTAŞ C., ÖZTÜRK FİNCAN G. S., TANER M. E.

1 st International Urban Environment Health Congress, 11 - 15 May 2016, (Summary Text)

16. GAZİ ÜNİVERSİTESİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ NİN2015 YILI TIBBİ ATIK MİKTARI VE BERTARAF MALİYET ANALİZİ

ÖNEN H. İ., YILMAZ-DEMİRTAŞ C., ÖZTÜRK FİNCAN G. S., TANER M. E.

1.st International Urban Environment Health Congress, 11 - 15 May 2016, (Summary Text)

17. GAZİ ÜNİVERSİTESİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ NİN2014 ve 2015 YILLARINA AİT TEHLİKELİ ATIK MİKTARI VE BERTARAFMALİYETİ

ÖZTÜRK FİNCAN G. S., ÖNEN H. İ., YILMAZ-DEMİRTAŞ C., TANER M. E.

1.st International Urban Environment Health Congress, 11 - 15 May 2016, (Summary Text)

18. LABORATUVAR TIBBİ ATIKLARININ İMHASI VECİHAZ ATIKLARININ NÖTRALİZASYONUNDA TÜRKİYE DEKİ SONDURUM

YILMAZ-DEMİRTAŞ C., ÖZTÜRK FİNCAN G. S., ÖNEN H. İ., TANER M. E.

1.st International Urban Environment Health Congress, 11 - 15 May 2016, (Summary Text)

19. The Relationship between SETD2 JMJD2C and TIP60 mRNA Expression Levels and Non Small Cell Lung Carcinoma

Demiröz M. Ş., Önen H. İ., Çelik A., Alp E., Sayan M., Kurul İ. C., et al.

Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation, Bangkok, Thailand, 19 - 22 December 2012, (Summary Text)

20. CGP52411 an Inhibitor of the EGFR Signalling Pathway Enhances the Chemosensitivity of Laryngeal Squamous Carcinoma Cells to Cisplatin

Menevşe A., Ergin V., Önen H. İ., Alp E.

Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation, Bangkok, Thailand, 19 - 22 December 2012, (Summary Text)

21. Synergistic antitumor activity of mTOR ınhibitor RAD001 and HDAC inhibitors LBH589 MS275 and Salermide on pancreatic cancer cell line BxPC 3

Alp E., Önen H. İ., Yılmaz A., Çobanoğlu G., Gökçe Ö., Özkan A., et al.

Molecular Medicine Conference, Alternative Strategies Against Cancer and Inflammation, Bangkok, Thailand, 19 - 22 December 2012, (Summary Text) Sustainable Development

22. Flavopridol has antiproliferative and apoptotic effects in malignant melanoma

Gökçe Ö., Doğan İ., Önen H. İ., Erdem Ö., Ergüven Kaya E., Ekmekçi A.

The 4th EMBO Meeting, Nice, France, 22 - 25 September 2012, (Summary Text)

23. KÜÇÜK HÜCRELİ DIŞI AKCİĞER KANSERİNDE ANTİAPOPTOTİK GENLERİN (BCL2 VE BCL2L1) MRNA DÜZEYİNDE EKSPRESYONLARININ ARAŞTIRILMASI

DEMİRÖZ Ş. M., ÇELİK A., ÖNEN H. İ., SAYAN M., KURUL İ. C., KONAÇ E., et al.

TÜSAD 33. YILLIK ULUSAL KONGRE, Turkey, 15 - 19 October 2011, (Summary Text) Sustainable Development

24. İnsan mesane kanseri hücre hattında (T24) WNT antagonistlerinin epigenetik düzenlenmelerle apoptoz yolağındaki genlerin ifade edilmesine olan etkileri.

Varol N., Konaç E., Önen H. İ., Gürocak Ö. S., Alp E., Yılmaz A., et al.

10. Üroonkoloji Kongresi, Antalya, Turkey, 26 - 30 October 2011, (Unpublished) Sustainable Development

25. Malign plevral mezotelyoma hücre hattında (MSTO-211H) histon asetil transferaz inhibitörü olan anakardik asit’in sisplatin cevabını arttırıcı etkisi

Önen H. İ., Yılmaz A., Alp E., Çelik A., Demiröz Ş. M., Menevşe E. S.

TÜSAD 33. Ulusal Kongresi - Solunum 2011, İzmir, Turkey, 15 - 19 October 2011, (Unpublished)

26. Deneysel akut akciğer iskemi-reperfüzyon hasarında Everolimus’un proinflamatuar genlerin ekspresyonu üzerine olan etkisi.

Çelik A., Demiröz Ş. M., Önen H. İ., Konaç E.

TÜSAD 33. Ulusal Kongresi - Solunum 2011, İzmir, Turkey, 15 - 19 October 2011, (Unpublished)

27. The effects of everolimus alone or in combination with sequential administration of oxaliplatin on human mesothelial Met 5A and Malignant pleural mesothelioma MSTO 211H cancer cells

Önen H. İ., Yılmaz A., Alp E., Çelik A., Konaç E., Kurul İ. C., et al.

EACR-Anticancer Agents Research Congress, Antalya, Turkey, 13 - 16 October 2011, (Summary Text) Sustainable Development

28. Sequential administration of EF24 A Novel Curcumin Analog and Cisplatin in Human Mesothelial Met 5A and Malignant pleural mesothelioma MSTO 211H cancer cells

Menevşe E. S., Alp E., Yılmaz A., Çelik A., Konaç E., Kurul İ. C., et al.

EACR-Anticancer Agents Research Congress, Antalya, Turkey, 13 - 16 October 2011, (Summary Text) Sustainable Development

29. To determine the effects of anticancer drugs targeting the survival pathways on the expression profiles of the apoptotic and antiapoptotic genes

Alp E., Yılmaz A., Önen H. İ., Menevşe E. S.

EACR-Anticancer Agents Research Congress, Antalya, Turkey, 13 - 16 October 2011, (Summary Text)

30. 1 8 GHz Frekanslı Modüleli Radyofrekans RF Radyasyon ve Demir III Klorür Uygulamasının Burkitt Lenfoma Raji Hücre Hattındaki Etkilerinin Araştırılması

Eşmekaya M. A., Alp E., Önen H. İ., Aral B., Canseven Kurşun A. G., Menevşe E. S., et al.

Elektromanyetik Alanlar ve Etkileri Sempozyumu, İstanbul, Turkey, 7 - 08 October 2011, pp.1-2, (Full Text)

31. Küçük Hücreli Dışı Akciğer Kanseri Gelişiminde AKT MTOR Sinyal İletim Yolağının Rolü

DEMİRÖZ Ş. M., ÇELİK A., SAYAN M., ÖNEN H. İ., KURUL İ. C., KONAÇ E., et al.

TÜSAD 33. Ulusal Kongresi, İzmir, Turkey, 09 September 2011, (Full Text)

32. Deneysel akut akciğer iskemi reperfüzyon hasarında everolimus un proinflamatuar genlerin ekspresyonu üzerine olan etkisi

ÇELİK A., DEMİRÖZ Ş. M., ÖNEN H. İ., KONAÇ E., KURUL İ. C.

TÜSAD 33. Ulusal Kongresi, İzmir, Turkey, 09 September 2011, (Full Text)

33. Küçük Hücreli Dışı Akciğer Kanserinde Antiapoptotik Genlerin BCL2 ve BCL2L1 mRNA Düzeyinde Ekspresyonlarının Araştırılması

DEMİRÖZ Ş. M., ÇELİK A., ÖNEN H. İ., SAYAN M., KURUL İ. C., KONAÇ E., et al.

TÜSAD 33. Ulusal Kongresi, İzmir, Turkey, 09 September 2011, (Full Text)

34. Effects of meloxicam lornoxicam alone and in combination with chemotherapeutic agents on the RAF MEK ERK pathway in Raji cells

Önen H. İ., Yılmaz A., Alp E., Yar A. S., Konaç E., Menevşe E. S.

The 15th World Congress inAdvances on Oncology and 13th International Symposium on Molecular Medicine, Athens, Greece, 7 - 09 October 2010, vol.26, pp.60, (Summary Text)

35. The pan deacetylase inhibitor panobinostat inhibits growth of human burkitt’s lymphoma cell line (Raji)

Önen H. İ., Doğan Turaçlı İ., Ergin V., Konaç E., Ekmekçi A., Menevşe A.

15th World Congress on Advances in Oncology and 13th International Symposium on Molecular Medicine, Athens, Greece, 7 - 09 October 2010, (Unpublished)

36. Comparison of endometrial IGF2 and H19 gene expressions in fertile groups and patients with implantational failure succeeding IVF treatment.

Korucuoğlu Ü., Asyalı Biri A., Konaç E., Önen H. İ., Alp E., İlhan M. N., et al.

The EMBO Meeting, Barcelona, Spain, 4 - 07 September 2010, (Unpublished)

Books 4

Metrics

Publication

133

Publication (WoS)

Publication (Scopus)

Citation (WoS)

743

H-Index (WoS)

Citation (Scopus)

816

H-Index (Scopus)

Citation (Scholar)

1297

H-Index (Scholar)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sobiad)

H-Index (Sobiad)

Citation (Sum Other)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Publications & Works

Publication

Publication (WoS)

Publication (Scopus)

Citation (WoS)

H-Index (WoS)

Citation (Scopus)

H-Index (Scopus)

Citation (Scholar)

H-Index (Scholar)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sobiad)

H-Index (Sobiad)

Citation (Sum Other)

Project

Thesis Advisory

Open Access